I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 7 studies | 19% ± 3% | |
| CD8-positive, alpha-beta T cell | 6 studies | 22% ± 9% | |
| epithelial cell | 5 studies | 30% ± 10% | |
| ciliated cell | 5 studies | 24% ± 4% | |
| effector CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| exhausted T cell | 3 studies | 22% ± 5% | |
| non-classical monocyte | 3 studies | 25% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% | |
| endothelial cell | 3 studies | 22% ± 5% | |
| regulatory T cell | 3 studies | 16% ± 0% | |
| macrophage | 3 studies | 21% ± 4% | |
| dendritic cell | 3 studies | 29% ± 5% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 3% |
